Cytotoxic trans-oriented platinum complexes only form adducts with single-stranded oligodeoxynucleotides

The reactions of the anticancer complex trans-[PtCl(2)[(E)-HN==C(OMe)Me](2)] (trans-EE) with both single-stranded and double-stranded deoxyribonucleotides have been studied by HPLC and 2D [(1)H,(15)N] HMQC NMR spectroscopy and compared with those of cis-[PtCl(2)(NH(3))(2)] (cis-DDP). Reactions of trans-EE with the single-stranded oligonucleotides d(CCTCGCTCTC) and d(CCTGGTCC) proceed rapidly through solvolysis of the starting substrate and subsequent formation of G-N7/monochloro trans-EE adducts. The rate of reaction is comparable to that of formation of an adduct from trans-EE and the dinuclotide d(ApG). Quite unexpectedly, the double-helical duplexes, d(TATGGTACCATA)(2) and d(TATGGCCATA)(2), with no terminal G residues, are practically inert towards trans-EE, and only minor species (< 5 % as estimated from HPLC traces) appear during 24 h reaction time. However, the duplexes d[(CCTCGCTCTC). (GAGAGCGAGG)] and d(GATAGGCCTATC)(2), which contain both terminal and central G residues, undergo platination only at the terminal, solvent-exposed, G residues, thereby confirming that the interior of the duplex is not accessible to trans-EE due to steric hindrance. In contrast, cis-DDP was found to bind exclusively to the central GG pair in d(GATAGGCCTATC)(2).     

Liquid-phase microextraction utilising plant oils as intermediate extraction medium--towards elimination of synthetic organic solvents in sample preparation

Hollow fibre based liquid-phase microextraction (LPME) using fatty oils and essential oils as the organic phase was evaluated to develop sample preparation technology eliminating the use of hazardous organic solvents. Basic drugs were extracted from different aqueous samples (0.2 to 1 mL) through approximately 15 microL of either almond oil, arachis oil, olive oil, soy-bean oil, anise oil, fennel oil, lavender oil, or peppermint oil (organic phase) immobilised within the pores of a polypropylene hollow fibre and into 20 microL of 10 mM HCOOH (acceptor phase) present inside the lumen of the hollow fibre. The extraction performance of the essential oils was comparable with the solvents normally used in LPME (dihexyl ether, n-octanol, and dodecyl acetate) in terms of extraction recovery and extraction speed. Whereas all essential oils tested were compatible with human urine, only anise oil was successful for plasma. The fatty oils provided lower recoveries than the essential oils due to higher viscosity, but all the fatty oils were compatible both with urine and plasma samples. In spite of the multi-component nature of the oils tested, they were not found to seriously contaminate the acceptor phases during extraction. In conclusion, fatty oils and essential oils may serve as alternative organic phase in LPME, eliminating the use of hazardous organic solvents.     

Cyclodextrins in Eye Drop Formulations

Ideally, eye drop formulations are aqueous solutions. Many drugs that are useful in topical application to the eye are not sufficiently water soluble to be dissolved in simple aqueous solutions. This problem is approached through hydrophilic prodrugs, suspensions, lipid based solutions and excipients such as cyclodextrins. Cyclodextrins can be used to form aqueous eye drop solutions with lipophilic drugs, such as steroids. The cyclodextrins increase the water solubility of the drug, enhance drug absorption into the eye, improve aqueous stability and reduce local irritation. Cyclodextrins are useful excipients in eye drop formulations of various ophthalmic drugs, including steroids of any kind, carbonic anhydrase inhibitors, pilocarpine and cyclosporins. Their use in ophthalmology has already begun and it is likely to expand the selection of drugs available as eye drops. In this paper we review the use of cyclodextrins in eye drop formulations. The use of cyclodextrins to formulate dexamethasone eye drops is an example of their usefulness. Cyclodextrins have been used to formulate eye drops containing corticosteroids, such as dexamethasone, with concentration and ocular absorption, which in human and animal studies is many fold that seen with presently available formulations. Such formulations offer the possibility of once a day application of corticosteroid eye drops after eye surgery, and more intensive topical steroid treatment in severe inflammation.     

A fast algorithm for estimating large-scale permeabilities of correlated anisotropic media

The problem of estimating large-scale permeabilities of reservoirs based on knowledge of the small-scale permeabilities is addressed. We present an accurate and fast algorithm to calculate the global permeabilities of two- or three-dimensional correlated and anisotropic block samples, thus providing a fast algorithm for obtaining grid block permeabilities for reservoir simulators from small scale data. The algorithm is tested on both two- and three-dimensional tube networks generated from real images and fractal forgeries modeling porous media. In almost all cases, the algorithm estimates the correct global permeability (calculated using exact but slow algorithms) of the network to better than 5%. The new algorithm is comparable in speed to conventional averaging techniques, such as the geometric mean, but the obtained estimates are always much better.List of Symbols K permeability of network (global permeability - K _e estimated permeability - K K×(L_x×L_y)/L_z - K permeability perpendicular to layering - K permeability parallel with layering - L _x, L_y, L_z Network size inx, y andz-directions - L Size of quadratic (cubic) network - Q global flux through network - U Q/(L_x×L_y), Darcy velocity (flux per unit area) - V volume of network - P pressure drop across network - a,b parameters in Equation (4) - P _i pressure at sitei - q _ij flux between nodesi andj - parameter of Pareto distribution - porosity - K(i) permeability at site (block)i - K _ij permeability of bond between nodesi andj - K _min minimumk(i) for sample - K _max maximumK(i) for sample - fluid viscosity     

Liquid-phase microextraction based on carrier mediated transport combined with liquid chromatography-mass spectrometry. New concept for the determination of polar drugs in a single drop of human plasma

Recently, we demonstrated for the first time liquid-phase microextraction (LPME) of polar drugs based on carrier mediated transport. In this new extraction technique, selected analytes were extracted as ion-pairs from small volumes of biological samples, through a thin layer of a water immiscible organic solvent immobilised in the pores of a porous hollow fibre (liquid membrane), and into a microl volume of an acidic aqueous acceptor solution placed inside the lumen of the hollow fibre. In the current paper, this new extraction technique was combined with liquid chromatography-mass spectrometry (LC-MS) for the first time. Carrier mediated LPME was evaluated for several new model drugs (0.01 相似文献   

Synthesis and some chemical properties of 3,3,4,4-tetraethoxybut-1-yne

Ring opening of 1,1-dibromo-2-chloro-2-diethoxymethylcyclopropane in a mixture of ethanol and dichloromethane with 50% aqueous sodium hydroxide in the presence of triethylbenzylammonium chloride (TEBA) gave 3,3,4,4-tetraethoxybut-1-yne (TEB) in excellent yield. This alkyne appears to be thermally stable at least up to 150 °C. The compound is also stable in neutral and basic aqueous solutions. In acidic aqueous media, however, TEB is unstable and was converted to one or several products depending on the reaction conditions. The most useful reaction appears to be deketalization to give 1,1-diethoxybut-3-yn-2-one, which was obtained in quantitative yield under the optimum conditions.     

Accurate interface-tracking for arbitrary Lagrangian–Eulerian schemes

We present a new method for tracking an interface immersed in a given velocity field which is particularly relevant to the simulation of unsteady free surface problems using the arbitrary Lagrangian–Eulerian (ALE) framework. The new method has been constructed with two goals in mind: (i) to be able to accurately follow the interface; and (ii) to automatically achieve a good distribution of the grid points along the interface. In order to achieve these goals, information from a pure Lagrangian approach is combined with information from an ALE approach. Our implementation relies on the solution of several pure convection problems along the interface in order to obtain the relevant information. The new method offers flexibility in terms of how an “optimal” point distribution should be defined. We have proposed several model problems, each with a prescribed time-dependent velocity field and starting with a prescribed interface; these problems should be useful in order to validate the accuracy of interface-tracking algorithms, e.g., as part of an ALE solver for free surface flows. We have been able to verify first, second, and third order temporal accuracy for the new method by solving these two-dimensional model problems.